Prediction of the secondary structure of HIV-1 gp120

被引:0
|
作者
Hansen, JE
Lund, O
Nielsen, JO
Brunak, S
Hansen, JES
机构
[1] TECH UNIV DENMARK, CTR BIOL SEQUENCE ANAL, DK-2800 LYNGBY, DENMARK
[2] UNIV COPENHAGEN, HVIDOVRE HOSP, INFECT DIS LAB, DK-2650 COPENHAGEN, DENMARK
[3] TECH UNIV DENMARK, DEPT PHYS, DK-2800 LYNGBY, DENMARK
关键词
HIV-1; gp120; secondary structure; prediction; multiple alignment; CD4-binding site;
D O I
10.1002/(SICI)1097-0134(199605)25:1<1::AID-PROT1>3.0.CO;2-N
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The secondary structure of HIV-1 gp120 was predicted using multiple alignment and a combination of two independent methods based on neural network and nearest-neighbor algorithms. The methods agreed on the secondary structure for 80% of the residues in BH10 gp120. Six helices were predicted in HIV strain BH10 gp120, as well as in 27 other HIV-1 strains examined, Two helical segments were predicted in regions displaying profound sequence variation, one in a region suggested to be critical for CD4 binding. The predicted content of helix, beta-strand, and coil was consistent with estimates from Fourier transform infrared spectroscopy. The predicted secondary structure of gp120 compared well with data from NMR analysis of synthetic peptides from the V3 loop and the C4 region. As a first step towards modeling the tertiary structure of gp120, the predicted secondary structure may guide the design of future HIV subunit vaccine candidates. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] HIV-1 gp120 and immune network
    Metlas, R
    Veljkovic, V
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2004, 23 (5-6) : 413 - 422
  • [2] STRUCTURE AND COMPARISON OF HIV-1 GP120 PEPTIDES IN COMPLEX WITH HIV-1 NEUTRALIZING FABS
    Stanfield, R. L.
    Ghiara, J. B.
    Rini, J. M.
    Stura, E. A.
    Satterthwait, A. C.
    Wilson, I. A.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C224 - C225
  • [3] HETEROGENEITY IN THE OLIGOSACCHARIDE STRUCTURE OF THE ENVELOPE GLYCOPROTEIN (GP120) OF HIV-1
    RANAJIT, P
    VERONESE, FD
    NAIR, B
    SARNGADHARAN, M
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 947 - 947
  • [4] Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
    Lekkerkerker, AN
    Ludwig, IS
    van Vliet, SJ
    van Kooyk, Y
    Geijtenbeek, TBH
    [J]. VIROLOGY, 2004, 329 (02) : 465 - 476
  • [5] Solution Structural Analysis of the Secondary Structure for HIV-1 gp120 Outer Domain by NMR Spectroscopy
    Sastry, M.
    Xu, L.
    Bhattacharya, S.
    Nabel, G. J.
    Bewley, C. A.
    Kwong, P. D.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A27 - A28
  • [6] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769
  • [7] VARIABILITY IN THE SLWDQ SEQUENCE OF HIV-1 GP120
    BEX, F
    VANHULLE, C
    KIERMER, V
    BURNY, A
    ZAGURY, JF
    ZAGURY, D
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S41 - S41
  • [8] Recombination property of the HIV-1 gp120 gene
    Prljic, J
    Veljkovic, N
    Veljkovic, V
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2004, 23 (5-6) : 447 - 454
  • [9] BINDING OF HIV-1 GP120 TO THE NICOTINIC RECEPTOR
    BRACCI, L
    LOZZI, L
    RUSTICI, M
    NERI, P
    [J]. FEBS LETTERS, 1992, 311 (02) : 115 - 118
  • [10] Conformation of the HIV-1 gp120 envelope glycoprotein
    Sodroski, J
    Wyatt, R
    Olshevsky, U
    Olshevsky, V
    Moore, J
    [J]. DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 184 - 187